Gayer Charles K insider trades
Gayer Charles K has filed 12 Form 4s with the SEC that we hold, all for Biocryst Pharmaceuticals INC (BCRX), as President and CCO. Across all of them we count 1 purchase worth $164.1K and 1 sale worth $66.5K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 30,000 shares of Biocryst Pharmaceuticals INC worth $164.1K, dated 2024-05-13. The first filing on our record is dated 2021-12-16 and the latest 2025-12-23.
Biocryst Pharmaceuticals INC (BCRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-15 | S, sale reported on Form 4 | 6,100 | $66.5K | 2022-12-19 |
| 2024-05-13 | P, purchase reported on Form 4 | 30,000 | $164.1K | 2024-05-15 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1800110) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms